scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.EJMECH.2018.02.007 |
P698 | PubMed publication ID | 29454190 |
P50 | author | Antonio Rescifina | Q40364172 |
Ignazio Barbagallo | Q47757242 | ||
Valeria Sorrenti | Q48139552 | ||
Agostino Marrazzo | Q55714836 | ||
Giuseppe Floresta | Q60992936 | ||
Valeria Pittalà | Q79207229 | ||
Loredana Salerno | Q87561855 | ||
Orazio Prezzavento | Q88469817 | ||
P2093 | author name string | Emanuele Amata | |
Giuseppe Romeo | |||
P2860 | cites work | DataWarrior: an open-source program for chemistry aware data visualization and analysis | Q30882770 |
P921 | main subject | hydrophobicity | Q41854968 |
P304 | page(s) | 54-62 | |
P577 | publication date | 2018-02-09 | |
P1433 | published in | European Journal of Medicinal Chemistry | Q3008624 |
P1476 | title | Potholing of the hydrophobic heme oxygenase-1 western region for the search of potent and selective imidazole-based inhibitors. | |
P478 | volume | 148 |
Q60948547 | A Pseudouridine Isoxazolidinyl Nucleoside Analogue Structural Analysis: A Morphological Approach |
Q57467576 | A Structure- and Ligand-Based Virtual Screening of a Database of "Small" Marine Natural Products for the Identification of "Blue" Sigma-2 Receptor Ligands |
Q60946685 | FABP4 inhibitors 3D-QSAR model and isosteric replacement of BMS309403 datasets |
Q64249373 | Fourfold Filtered Statistical/Computational Approach for the Identification of Imidazole Compounds as HO-1 Inhibitors from Natural Products |
Q89287854 | Heme Oxygenase Inhibition Sensitizes Neuroblastoma Cells to Carfilzomib |
Q64930299 | Heme Oxygenase-1 Inhibition Sensitizes Human Prostate Cancer Cells towards Glucose Deprivation and Metformin-Mediated Cell Death. |
Q90309042 | New Arylethanolimidazole Derivatives as HO-1 Inhibitors with Cytotoxicity against MCF-7 Breast Cancer Cells |
Q89706191 | Non-competitive heme oxygenase-1 activity inhibitor reduces non-small cell lung cancer glutathione content and regulates cell proliferation |
Q60503345 | Novel Structural Insight into Inhibitors of Heme Oxygenase-1 (HO-1) by New Imidazole-Based Compounds: Biochemical and In Vitro Anticancer Activity Evaluation |
Q91485205 | Repurposing of FDA-Approved Drugs for Treating Iatrogenic Botulism: A Paired 3D-QSAR/Docking Approach† |
Q58539514 | iVS analysis to evaluate the impact of scaffold diversity in the binding to cellular targets relevant in cancer |
Search more.